Multimodal wireless electrical stimulation for tissue regeneration
Multimodal wireless electrical stimulation for tissue regeneration
批准号:
10615764
负责人:
Song Li
金额:
$47.23万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2027-04-30
关键词:
AccelerationAddressAmericanAtrophicAutologousAxonClinicalDevelopmentDevicesDistalDrug Delivery SystemsElectric StimulationElectrodesGoalsGrowthHealthcareImplantInjuryMedicalMuscleMuscular AtrophyNanotechnologyNatural regenerationNerveNeuromuscular JunctionNeuronsOperative Surgical ProceduresOutcomePatientsPeripheralPeripheral NervesPeripheral nerve injuryPhysical therapyPhysiciansPilot ProjectsPreventionProtocols documentationRecovery of FunctionRegenerative MedicineRegenerative capacityRegenerative engineeringResearch PersonnelStem cell transplantSystemTechnologyTestingTherapeuticTimeUnited StatesWorkaxon growthaxon regenerationaxonal sproutingbioelectronicsimprovedinjuredinnovationminiaturizeminimally invasivemultidisciplinarymultimodalitymuscle degenerationnerve injuryneuromuscularneuromuscular rehabilitationnovelnovel strategiespoint of careprogramsregenerative therapyreinnervationrepairedsciatic nervesynergismtherapy outcometissue regenerationwirelesswireless electronic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Twenty million Americans suffer from peripheral nerve injury, which results in approximately
$150 billion health-care expenses annually in the United States. Approximately half of patients treated
with nerve grafts have an inadequate level of function. Twenty million Americans suffer from peripheral
nerve injury, which results in approximately $150 billion health-care expenses annually in the United
States. Among various factors, axon growth rate and the lack of reinnervation and neuromuscular
regeneration are two major road barriers. In many cases, during peripheral regeneration, the muscle
undergoes atrophy and becomes un-receptive to reinnervation, and even the sprouting axons that
regenerate across the gap cannot form functional neuromuscular junctions (NMJs). While most of the
previous studies focus on accelerating peripheral nerve growth, novel approaches to maintain the
neuromuscular receptivity and delay the degeneration of muscle need to be developed and integrated.
Therefore, an integrative approach that combines the acceleration of axon growth and the prevention
of muscle degeneration is required to address this unmet medical need, and we propose to use
multimodal electrical stimulation (ES) to achieve this goal. Our recent studies have shown that repetitive
ES either at the proximal or distal stumps of transected nerve can be more effective than one-time ES
to further improve the therapeutic outcome, but their relative contributions to and their combined effects
on axon growth, the slow-down of muscle atrophy and reinnervation remain to be investigated.
Therefore, to investigate the potential synergistic effects of proximal and distal ES, we hypothesize
that programmable ES at the proximal and distal stumps of sciatic nerve following a transection injury
can promote axon growth and maintain muscle receptivity respectively and synergize neuromuscular
regeneration. We will test this hypothesis by developing a wireless, stretchable, bioresorbable and
miniaturized system that allows repetitive ES with versatile protocols. To address the aforementioned
challenges and test our hypothesis, we have assembled a multidisciplinary team, and performed pilot
studies to demonstrate the feasibility. We propose three Specific Aims: (1) To develop and
characterize a bioresorbable, stretchable and wireless bioelectronic device for repetitive electrical
stimulation. (2) To determine how the time periods of repetitive proximal and distal ES regulate muscle
functional recovery. (3) To investigate the combined effects of proximal and distal ES on neuromuscular
regeneration. This proposed project is timely with the recent advancement in regenerative engineering,
micro/nanotechnologies, miniaturized wireless point-of-care devices, and bioresorbable and stretchable
electrodes. This innovative bioelectronic device provides a novel and minimally invasive approach for
neuromuscular regeneration, and will have wide applications in regenerative medicine and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combination Therapy for Pancreatic Cancer
-
批准号:10581174
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2023
-
负责人:Song Li
-
依托单位:
Nanoparticles-mediated combination therapy for breast cancer
-
批准号:10617544
-
项目类别:
-
资助金额:$51.62万
-
财政年份:2023
-
负责人:Song Li
-
依托单位:
Mechanopriming for cell engineering
-
批准号:10737574
-
项目类别:
-
资助金额:$50.84万
-
财政年份:2023
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10703786
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2022
-
负责人:Song Li
-
依托单位:
Regulation of cell reprogramming by matrix stiffness
-
批准号:10281141
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2021
-
负责人:Song Li
-
依托单位:
Regulation of cell reprogramming by matrix stiffness
-
批准号:10491279
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2021
-
负责人:Song Li
-
依托单位:
Regulation of cell reprogramming by matrix stiffness
-
批准号:10687264
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2021
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10442707
-
项目类别:
-
资助金额:$8.14万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10202507
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
-
批准号:10668316
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Therapeutic microneedles for localized treatment of periodontal tissue
-
批准号:10008033
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
-
批准号:10206060
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
-
批准号:10426123
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Study of Interleukin 33 as a new immunotherapy of lung cancer
-
批准号:10654777
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2019
-
负责人:Song Li
-
依托单位:
Towards Glucose Transporter-Mediated Glucose-Responsive Insulin Delivery with Fast Response
-
批准号:10425401
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:Song Li
-
依托单位:
Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer
-
批准号:10063859
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2017
-
负责人:Song Li
-
依托单位:
Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer
-
批准号:10307546
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2017
-
负责人:Song Li
-
依托单位:
In Situ Regeneration of Blood Vessel
-
批准号:9022513
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2015
-
负责人:Song Li
-
依托单位:
Nanomicellar Formulation for Synergistic Targeting of Prostate Cancer
-
批准号:8530621
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2013
-
负责人:Song Li
-
依托单位:
Rational Design of Lipidic Vectors for Mitochondria-Targeted Antioxidants
-
批准号:8689109
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2013
-
负责人:Song Li
-
依托单位:
海外基金